COSM

Cosmos Health Inc.

Insider Trades

NameValueActionPriceCurrent Price
Terzis GeorgiosChief Financial Officer
$42k168.1k shares
BuyJun 16, 2026
$0.2498
$0.2417
Siokas GrigoriosDirector, 10 Percent Owner, Officer: Chief Executive Officer
$160k701.4k shares
BuyJun 10, 2026
$0.2281
$0.21
Siokas GrigoriosDirector, 10 Percent Owner, Officer: Chief Executive Officer
$150k257.3k shares
BuyDec 20, 2024
$0.5829
--
Terzis GeorgiosChief Financial Officer
$50k85.8k shares
BuyDec 20, 2024
$0.5829
--
Siokas GrigoriosDirector, 10 Percent Owner, Officer: Chief Executive Officer
$100k163.7k shares
BuyJan 13, 2025
$0.611
--
Siokas GrigoriosDirector, 10 Percent Owner, Officer: Chief Executive Officer
$60k87.2k shares
BuyJan 14, 2025
$0.6877
--

News

globenewswire.comCosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profitglobenewswire.comJun 12globenewswire.comCosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolioglobenewswire.comJun 11globenewswire.comCosmos Health Secures Additional 180-Day Nasdaq Extension to Regain Bid Price Complianceglobenewswire.comJun 11globenewswire.comCosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessariesglobenewswire.comJun 10globenewswire.comCosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underwayglobenewswire.comJun 10